-+ 0.00%
-+ 0.00%
-+ 0.00%

Medicenna Therapeutics Q1 EPS $(0.06), Inline

Benzinga·08/14/2026 11:11:59
Listen to the news
Medicenna Therapeutics (TSX:MDNA) reported quarterly losses of $(0.06) per share which met the analyst consensus estimate. This is unchanged from the same period last year.